Overview
Spastic ataxia (Orphanet code 316226) is a clinical grouping term that encompasses a spectrum of rare neurological disorders characterized by the combined presence of both spasticity (increased muscle tone and stiffness due to upper motor neuron dysfunction) and cerebellar ataxia (impaired coordination and balance due to cerebellar dysfunction). These conditions affect the central nervous system, primarily involving the corticospinal tracts (which control voluntary movement) and the cerebellum (which coordinates movement and balance). The combination of spastic paraplegia and cerebellar ataxia reflects overlapping neurodegeneration in these two motor systems. Patients with spastic ataxia typically present with progressive difficulty walking due to both stiffness and unsteadiness, impaired coordination of limbs, dysarthria (slurred speech), abnormal eye movements such as nystagmus, and hyperreflexia with extensor plantar responses. Additional features may include peripheral neuropathy, cognitive impairment, urinary dysfunction, and skeletal deformities depending on the specific genetic subtype. The severity and age of onset vary considerably across the different subtypes grouped under this umbrella term. Spastic ataxia includes multiple genetic subtypes with both autosomal recessive and autosomal dominant inheritance patterns, involving various genes such as MARS2 (SPAX3), KIF1C (SPAX2/SAX2), MTPAP (SPAX4), and AFG3L2 (SPAX5), among others. Charlevoix-Saguenay type spastic ataxia (ARSACS, caused by SACS gene mutations) is one of the best-characterized forms. There is currently no curative treatment for spastic ataxias. Management is supportive and symptomatic, including physical therapy, occupational therapy, antispasticity medications (such as baclofen or tizanidine), speech therapy, and assistive devices for mobility. Genetic counseling is recommended for affected families.
Also known as:
Variable
Can be inherited in different ways depending on the underlying gene
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
1 eventData sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Spastic ataxia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Spastic ataxia at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Spastic ataxia.
Community
No community posts yet. Be the first to share your experience with Spastic ataxia.
Start the conversation →Latest news about Spastic ataxia
Disease timeline:
New recruiting trial: At Home Use of Stimulation Suits for Managing MS Symptoms
A new clinical trial is recruiting patients for Spastic ataxia
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Spastic ataxia
What is Spastic ataxia?
Spastic ataxia (Orphanet code 316226) is a clinical grouping term that encompasses a spectrum of rare neurological disorders characterized by the combined presence of both spasticity (increased muscle tone and stiffness due to upper motor neuron dysfunction) and cerebellar ataxia (impaired coordination and balance due to cerebellar dysfunction). These conditions affect the central nervous system, primarily involving the corticospinal tracts (which control voluntary movement) and the cerebellum (which coordinates movement and balance). The combination of spastic paraplegia and cerebellar ataxia
Which specialists treat Spastic ataxia?
25 specialists and care centers treating Spastic ataxia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.